GNPX: Genprex, Inc. Stock

by  •  • Comments Off on GNPX: Genprex, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.49
Enterprise Value ($M) -2.25
Book Value ($M) 7.42
Book Value / Share 3.88
Price / Book 0.61
NCAV ($M) 4.28
NCAV / Share 2.04
Price / NCAV 1.05

Profitability (mra)
Return on Invested Capital (ROIC) -4.16
Return on Assets (ROA) -1.32
Return on Equity (ROE) -1.67

Liquidity (mrq)
Quick Ratio 2.31
Current Ratio 2.31

Balance Sheet (mrq) ($M)
Current Assets 7.53
Assets 10.67
Liabilities 3.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -31.08
Net Income -30.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -24.74
Cash from Investing -0.07
Cash from Financing 10.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A CVI Investments, Inc. 4.90 -10.86

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-21 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 7,591 22,843 33.23
2024-05-02 4,945 1,193 414.50
2024-05-01 3,385 3,115 108.67
2024-04-30 2,493 3,497 71.29
2024-04-29 583 637 91.52

(click for more detail)

Similar Companies
GLSI – Greenwich LifeSciences, Inc. GLTO – Galecto, Inc.
GNLX – Genelux Corporation GOVX – GeoVax Labs, Inc.
GTBP – GT Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io